Welcome to the international HTA database
Showing [3358 Records] Selected Records [0 Hits] [Clear]
| Year | Source | Title | |
|---|---|---|---|
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Fondaparinux for post-operative venous thrombosis prophylaxis | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Long-acting beta2-agonists for maintenance therapy of stable chronic obstructive pulmonary disease: a systematic review | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Heart failure: is there a role for angiotensin II receptor blockers? | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Prevalence of chronic pain: an overview | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Scleral support surgery for pathologic myopia | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Treatment of inoperable advanced non-small-cell lung cancer: regimens with or without taxane | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Drug eluting stents: managing coronary artery stenosis following PTCA | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | AHFMR screening procedure for use when considering the implementation of health technology | |
| 2002 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Endometrial ablation techniques in the treatment of dysfunctional uterine bleeding | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents: systematic review and budget impact analysis | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Digital mammography versus film-screen mammography: technical, clinical and economic assessments | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Local health technology assessment: a guide for health authorities | |
| 2002 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | Should the McGill University Health Center replace the Jelco/Cathlon catheter by the ProtectIVPlus catheter for intravenous infusions? | |
| 2002 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | Should the McGill University Health Centre initiate an antiviral treatment programme for patients with chronic hepatitis C? | |
| 2002 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | Should the McGill University Health Center use mitoxantrone in the treatment of multiple sclerosis? | |
| 2002 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | An evaluation of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions at the MUHC: is there a difference between the drugs? | |
| 2002 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Gamma knife and linear accelerator stereotactic radiosurgery | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | The Pediatric Economic Database Evaluation (PEDE) project | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Tiotropium bromide | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Ertapenem | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Etoricoxib | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Aripiprazole | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Darbepoetin alpha | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Glimepiride | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Treprostinil | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Tegaserod hydrogen maleate | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Valdecoxib | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Economic evaluation of population-based screening for colorectal cancer | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Breath test for the detection of impaired glucose tolerance | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Transmyocardial revascularization for treatment of angina | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Topical ozone therapy for the treatment of diabetic leg ulcers | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Virtual colonoscopy (computed tomography colonography) | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Efficacy of suicide prevention programs for children and youth | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Atomoxetine | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Accuracy and reliability of using computerized interpretation of electrocardiograms for routine examinations | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Percutaneous vertebroplasty: a bone cement procedure for spinal pain relief | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Continuous glucose monitoring in the management of diabetes mellitus | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Economic assessment: celecoxib and rofecoxib for patients with osteoarthritis or rheumatoid arthritis | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Four-dimensional ultrasound for prenatal diagnosis | |
| 2002 | WorkSafeBC | Marijuana for medicinal purposes: an evidence-based assessment | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Carotid stenting for the treatment of carotid artery stenosis | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Deep brain stimulation for patients with Parkinson's disease | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Photonic stimulation for the treatment of chronic pain | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Spinal manipulation for lower back pain | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Ultrasonic cutting and coagulating devices | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Extracorporeal immunoadsorption treatment for rheumatoid arthritis | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Computer-enhanced surgical systems ('robotic surgery') | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Activated protein C for severe sepsis | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | An assessment of oseltamivir for the treatment of suspected influenza | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Clinical and economic assessment: infliximab for the treatment of Crohn's disease | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Infliximab for the treatment of Crohn's disease: a systematic review and cost-utility analysis | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Radiofrequency catheter ablation for cardiac arrhythmias: a clinical and economic review | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Application of an assessment framework to an evolving telemental health program | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | A study of the impact of 2000-2001 HTA products | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Surgical treatment for chronic venous insufficiency | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Acupuncture: evidence from systematic reviews and meta-analyses | |
| 2002 | Medical Advisory Secretariat (MAS) | Endovascular repair of abdominal aortic aneurysm: an evidence-based analysis | |
| 2002 | Medical Advisory Secretariat (MAS) | Gamma knife: an evidence-based analysis | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Efficacy and/or effectiveness of spirometry and force oscillation technique in the diagnosis of childhood asthma | |
| 2002 | Medical Advisory Secretariat (MAS) | Bone anchored hearing aid (BAHA): an evidence-based analysis | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Metal-on-metal hip resurfacing for young, active adults with degenerative hip disease | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Priority setting in health care: from research to practice | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Cryosurgery for prostate cancer | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Intracoronary brachytherapy for the treatment of in-stent restenosis | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Stereotactic radiosurgery: an update | |
| 2002 | Institute for Clinical Evaluative Sciences (ICES) | Health technology assessment of positron emission tomography in oncology - a systematic review | |
| 2002 | Institute for Clinical Evaluative Sciences (ICES) | Prostate-specific antigen (PSA) screening in asymptomatic men | |
| 2002 | Canadian Task Force on Preventive Health Care (CTFPHC) | The use of back belts for prevention of occupational low back pain: systematic review and recommendations | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Using a spectral reflectance technique to measure transcutaneous bilirubin in neonates: a new device | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Does skin cholesterol testing provide benefit? | |
| 2002 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Home oxygen therapy for the treatment of cluster headache | |
| 2002 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | [Diagnostic radiology using transportable equipment] | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Alemtuzumab | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Amlexanox | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Caspofungin acetate | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Esomeprazole magnesium | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Galantamine | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Imatinib mesylate | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Levonorgestrel-releasing intrauterine system | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Nateglinide | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Parecoxib sodium | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Pleconaril | |
| 2001 | Institute for Clinical Evaluative Sciences (ICES) | Health technology assessment of PET (positron emission tomography) | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Rosuvastatin | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Sibutramine | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Tacrolimus | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Tegaserod | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Tenecteplase: single-bolus thrombolytic therapy for acute myocardial infarction | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Telithromycin | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Topical diclofenac sodium | |
| 2001 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Positron emission tomography in Quebec | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Antimicrobial bandages | |
| 2001 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Osteoporosis and fractures among people aged 65 and over: recommendations for an integrated framework for action in Quebec | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Computed tomography laser mammography | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Economic evaluation of zanamivir (relenza) for the treatment of influenza | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Given diagnostic imaging system | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Gliasite radiation therapy | |
| 2001 | Alberta Heritage Foundation for Medical Research (AHFMR) | Cyclosporine for the treatment of aplastic anemia | |
| 2001 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | GlucoWatch biographer |